Literature DB >> 16757432

CD7/CD19 double-positive T-cell acute lymphoblastic leukemia.

Shinya Fujisawa1, Fumihiko Tanioka, Toshihiko Matsuoka, Takachika Ozawa, Kensuke Naito, Masahide Kobayashi.   

Abstract

We report a rare case of T-cell acute lymphoblastic leukemia (T-ALL) with an aberrant phenotype. A 52-year-old man was admitted to our hospital because of lymph node (LN) swelling in the bilateral neck. A computed tomographic scan showed LN swelling in the mediastinum and a right pleural effusion. The tumor cells in the neck LN showed positivity for cytoplasmic CD3, CD7, CD19, and CD79a, whereas the tumor cells in the bone marrow (BM) showed positivity for CD10 and CD13 in addition to the former 4 antigens. The chromosomes in the BM were normal. Neither T-cell receptor gamma nor immunoglobulin heavy chain rearrangement was detected in the neck LN. We diagnosed this case as T-ALL with an aberrant phenotype and started the standard chemotherapy for ALL. The response was so effective that complete remission (CR) was easily attained. The patient is now under maintenance therapy in the first CR without hematopoietic cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757432     DOI: 10.1532/IJH97.05130

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  The value of c-kit in the diagnosis of biphenotypic acute leukemia. EGIL (European Group for the Immunological Classification of Leukaemias)

Authors: 
Journal:  Leukemia       Date:  1998-12       Impact factor: 11.528

2.  Large granular lymphocytic leukaemia with a mixed T-cell/B-cell phenotype.

Authors:  K Akashi; T Shibuya; M Nakamura; A Oogami; M Harada; Y Niho
Journal:  Br J Haematol       Date:  1998-02       Impact factor: 6.998

3.  Identification of clonogenic common lymphoid progenitors in mouse bone marrow.

Authors:  M Kondo; I L Weissman; K Akashi
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

Review 4.  Definition of acute biphenotypic leukemia.

Authors:  E Matutes; R Morilla; N Farahat; F Carbonell; J Swansbury; M Dyer; D Catovsky
Journal:  Haematologica       Date:  1997 Jan-Feb       Impact factor: 9.941

5.  Differential expression of WT1 gene product in non-Hodgkin lymphomas.

Authors:  Elias Drakos; George Z Rassidakis; Panagiota Tsioli; Raymond Lai; Dan Jones; L Jeffrey Medeiros
Journal:  Appl Immunohistochem Mol Morphol       Date:  2005-06

6.  B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

Authors:  L M Nadler; S J Korsmeyer; K C Anderson; A W Boyd; B Slaughenhoupt; E Park; J Jensen; F Coral; R J Mayer; S E Sallan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

7.  Acute lymphoblastic leukemia with the phenotype of a putative B-cell/T-cell bipotential precursor.

Authors:  Lee Gong Lau; Lip Kun Tan; Evelyn S C Koay; Melvin H L Ee; Suat Hoon Tan; Te Chih Liu
Journal:  Am J Hematol       Date:  2004-10       Impact factor: 10.047

Review 8.  Diagnostic role of tests for T cell receptor (TCR) genes.

Authors:  E Hodges; M T Krishna; C Pickard; J L Smith
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

Review 9.  Gallium-67 tumor scanning.

Authors:  S M Pinsky; R E Henkin
Journal:  Semin Nucl Med       Date:  1976-10       Impact factor: 4.446

10.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

Authors:  M C Bene; G Castoldi; W Knapp; W D Ludwig; E Matutes; A Orfao; M B van't Veer
Journal:  Leukemia       Date:  1995-10       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.